Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc (Bayl Univ Med Cent) ; 35(3): 328-331, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35518790

RESUMEN

Short sleep duration has been linked to the development of neurocognitive disorders. Still, current evidence for this relationship is conflicting. In this review, we summarize evidence regarding the relationship between short sleep duration and neurocognitive disorders, which shows that short sleep duration increases the risk of incident major neurocognitive disorders beginning as early as midlife. The pathological brain changes attributed to poor sleep may be related to changes in brain microstructure and accumulation of debris in the brain. More evidence is needed to fully understand the relationship between sleep duration and cognitive decline and the molecular changes that link the two. Measures of sleep quality such as sleep duration represent a potentially modifiable risk factor for the prevention of cognitive decline and neurocognitive disorders.

2.
Chem Sci ; 13(34): 9811-9832, 2022 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-36199638

RESUMEN

As highly versatile crystalline porous materials, covalent organic frameworks (COFs) have emerged as an ideal platform for developing novel functional materials, attributed to their precise tunability of structure and functionality. Introducing chiral functional units into frameworks produces chiral COFs (CCOFs) with chiral superiorities through chirality conservation and conversion processes. This review summarises recent research progress in CCOFs, including synthetic methods, chiroptical characterisations, and their applications in asymmetric catalysis, chiral separation, and enantioselective recognition and sensing. Challenges and limitations are discussed to uncover future opportunities in CCOF research.

3.
Nutrients ; 14(20)2022 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-36297069

RESUMEN

Background Emerging research suggests hyperglycemia can increase intestinal permeability. Ginger and its bioactive compounds have been reported to benefit diabetic animals due to their anti-inflammatory and antioxidant properties. In this study, we revealed the beneficial effect of gingerol-enriched ginger (GEG) on intestinal health (i.e., barrier function, mitochondrial function, and anti-inflammation) in diabetic rats. Methods Thirty-three male Sprague Dawley rats were assigned to three groups: low-fat diet (control group), high-fat-diet (HFD) + streptozotocin (single low dose 35 mg/kg body weight (BW) after 2 weeks of HFD feeding) (DM group), and HFD + streptozotocin + 0.75% GEG in diet (GEG group) for 42 days. Glucose tolerance tests (GTT) and insulin tolerance tests (ITT) were conducted at baseline and prior to sample collection. Total pancreatic insulin content was determined by ELISA. Total RNA of intestinal tissues was extracted for mRNA expression using qRT-PCR. Results Compared to the DM group, the GEG group had improved glucose tolerance and increased pancreatic insulin content. Compared to those without GEG (DM group), GEG supplementation (GEG group) increased the gene expression of tight junction (Claudin-3) and antioxidant capacity (SOD1), while it decreased the gene expression for mitochondrial fusion (MFN1), fission (FIS1), biogenesis (PGC-1α, TFAM), mitophagy (LC3B, P62, PINK1), and inflammation (NF-κB). Conclusions Ginger root extract improved glucose homeostasis in diabetic rats, in part, via improving intestinal integrity and mitochondrial dysfunction of GI health.


Asunto(s)
Diabetes Mellitus Experimental , Zingiber officinale , Masculino , Ratas , Animales , Estreptozocina , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Antioxidantes/farmacología , FN-kappa B/metabolismo , Claudina-3 , Superóxido Dismutasa-1/metabolismo , Ratas Sprague-Dawley , Dieta Alta en Grasa/efectos adversos , Insulina/metabolismo , Mitocondrias/metabolismo , Extractos Vegetales/uso terapéutico , Antiinflamatorios/farmacología , Glucosa/metabolismo , Proteínas Quinasas/metabolismo , ARN Mensajero/metabolismo , ARN/metabolismo
4.
J Alzheimers Dis ; 72(s1): S11-S35, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31104030

RESUMEN

The purpose of the 'First Regional Healthy Aging and Dementia Research Symposium' was to discuss the latest research in healthy aging and dementia research, public health trends related to neurodegenerative diseases of aging, and community-based programs and research studying health, nutrition, and cognition. This symposium was organized by the Garrison Institute on Aging (GIA) of the Texas Tech University Health Sciences Center (TTUHSC), and was held in Lubbock, Texas, October 24-25, 2018. The Symposium joined experts from educational and research institutions across the United States. The two-day Symposium included all GIA staff and researchers. Students, postdoctoral fellows, and faculty members involved in dementia research presented at the Symposium. Healthcare professionals, from geriatricians to social workers working with patients with neurodegenerative diseases, also presented. In addition, experts traveled from across the United States to participate. This event was comprised of multiple sessions, each with several oral presentations, followed by questions and answers, and discussion.


Asunto(s)
Investigación Biomédica/tendencias , Congresos como Asunto/tendencias , Demencia/epidemiología , Demencia/psicología , Envejecimiento Saludable/fisiología , Envejecimiento Saludable/psicología , Investigación Biomédica/métodos , Humanos , Texas/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA